GLP-1 AND FEMALE REPRODUCTIVE HEALTH: FERTILITY, CONTRACEPTION, AND GESTATIONAL SAFETY
Glucagon-like peptide-1 (GLP-1) receptor agonists are increasingly used in the treatment of type 2 diabetes mellitus and obesity, expanding their exposure among women of reproductive age. In addition to metabolic effects related to glycemic control and body weight reduction, the use of these medications raises specific...